Evidence map›Paper›PMID 26097678›Full record

ArticleCell & bioscience2015

Leishmaniases diagnosis: an update on the use of immunological and molecular tools.

Milena de Paiva-Cavalcanti, Rayana Carla Silva de Morais, Rômulo Pessoa-E-Silva, Lays Adrianne Mendonça Trajano-Silva, Suênia da Cunha Gonçalves-de-Albuquerque, Diego de Hollanda Cavalcanti Tavares, Maria Carolina Accioly Brelaz-de-Castro, Rafael de Freitas E Silva, Valéria Rêgo Alves Pereira

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Characterization ofTropical medicine and infectious disease · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Milena de Paiva-CavalcantiDepartment of Immunology, Aggeu Magalhães Research Center, Oswaldo Cruz Foundation, Av. Prof. Moraes Rego s / n, 50670-420 Recife, PE Brazil.
Rayana Carla Silva de MoraisDepartment of Immunology, Aggeu Magalhães Research Center, Oswaldo Cruz Foundation, Av. Prof. Moraes Rego s / n, 50670-420 Recife, PE Brazil.
Rômulo Pessoa-E-SilvaDepartment of Immunology, Aggeu Magalhães Research Center, Oswaldo Cruz Foundation, Av. Prof. Moraes Rego s / n, 50670-420 Recife, PE Brazil.
Lays Adrianne Mendonça Trajano-SilvaDepartment of Immunology, Aggeu Magalhães Research Center, Oswaldo Cruz Foundation, Av. Prof. Moraes Rego s / n, 50670-420 Recife, PE Brazil.
Suênia da Cunha Gonçalves-de-AlbuquerqueDepartment of Immunology, Aggeu Magalhães Research Center, Oswaldo Cruz Foundation, Av. Prof. Moraes Rego s / n, 50670-420 Recife, PE Brazil.
Diego de Hollanda Cavalcanti TavaresDepartment of Immunology, Aggeu Magalhães Research Center, Oswaldo Cruz Foundation, Av. Prof. Moraes Rego s / n, 50670-420 Recife, PE Brazil.
Maria Carolina Accioly Brelaz-de-CastroDepartment of Immunology, Aggeu Magalhães Research Center, Oswaldo Cruz Foundation, Av. Prof. Moraes Rego s / n, 50670-420 Recife, PE Brazil.
Rafael de Freitas E SilvaDepartment of Immunology, Aggeu Magalhães Research Center, Oswaldo Cruz Foundation, Av. Prof. Moraes Rego s / n, 50670-420 Recife, PE Brazil ; Department of Natural and Exact Sciences, University of Pernambuco (UPE), St. Capitão Pedro Rodrigues, 105, 55920-000 São José, Garanhuns, PE Brazil.
Valéria Rêgo Alves PereiraDepartment of Immunology, Aggeu Magalhães Research Center, Oswaldo Cruz Foundation, Av. Prof. Moraes Rego s / n, 50670-420 Recife, PE Brazil.
Fundação Oswaldo Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniases are caused by obligate intracellular protozoan parasites of the genus Leishmania. They cause a spectrum of diseases, most notably visceral (VL), cutaneous (CL), and mucosal (ML) leishmaniasis, which affect millions of people around the world, each year. Despite scientific advances, leishmaniases cases are expanding, constituting an important public health problem. Immunological and molecular diagnostic tools have been increasingly applied for the early detection of these parasitic infections, since the existence of limitations in clinical and parasitological examinations may provide false results, thus interfering in epidemiological research and diseases control. Although there is a great diversity of available immunological assays, important common deficiencies persist, which explains the current exploration of the molecular biology in research fields, especially the Polymerase Chain Reaction (PCR) and its variants, such as real-time quantitative PCR. However, in the last years, significant results have also been reached inside of immunological context (especially by Flow Cytometry), for humans and dogs, demonstrated by research works of the New and Old worlds. In spite of their potential to clarify and minimize the present global situation of the diseases, the implementation of molecular or immunological innovative reference assays for VL and CL at health services is still a challenge due to several reasons, including lack of standardization among laboratories and structural concerns. In this article we bring classical and current information about technological advances for the immunological and molecular leishmaniases diagnosis, their features, and applications.

Indexed as

Cutaneous leishmaniasisDiagnosisImmunological toolsMolecular toolsVisceral leishmaniasis

Identifiers

PMID26097678
PMCPMC4474361
OpenAlexW1605146840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.